Title:
【発明の名称】オキシブチニンの経皮投与
Document Type and Number:
Japanese Patent JPH08502952
Kind Code:
A
Abstract:
The present invention is directed to the transdermal administration of oxybutynin together with a suitable permeation enhancer. The invention includes a transdermal drug delivery device comprising a matrix adapted to be placed in oxybutynin- and permeation enhancer-transmitting relation with the skin site. The matrix contains sufficient amounts of a permeation enhancer and of oxybutynin, in combination, to continuously administer to the skin for a predetermined period of time the oxybutynin to provide an effective therapeutic result. The invention is also directed to a method for the transdermal administration of a therapeutically effective amount of oxybutynin together with a skin permeation-enhancing amount of a suitable permeation enhancer.
Inventors:
Lee, en suu
Ned Barge, Diane Yee
Yang, Sue Il
Ned Barge, Diane Yee
Yang, Sue Il
Application Number:
JP50372594A
Publication Date:
April 02, 1996
Filing Date:
May 13, 1993
Export Citation:
Assignee:
Alza Corporation
International Classes:
A61K9/00; A61K9/70; A61K31/135; A61K31/215; A61K31/216; A61K47/10; A61K47/14; A61K47/34; A61P13/02; A61P15/00; A61P25/00; (IPC1-7): A61K31/135; A61K9/70; A61K47/10; A61K47/14; A61K47/34
Attorney, Agent or Firm:
Kyozo Yuasa (6 people outside)